RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 117 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $22,732,800 | -8.3% | 15,360,000 | -10.2% | 0.30% | -10.9% |
| Q4 2023 | $24,795,000 | +34.0% | 17,100,000 | -0.2% | 0.34% | +19.4% |
| Q3 2023 | $18,506,880 | -16.1% | 17,136,000 | +0.2% | 0.28% | -11.3% |
| Q2 2023 | $22,059,000 | -1.8% | 17,100,000 | +0.4% | 0.32% | -1.5% |
| Q1 2023 | $22,471,680 | -11.6% | 17,024,000 | +0.4% | 0.32% | -27.0% |
| Q4 2022 | $25,434,000 | +524.3% | 16,956,000 | +391.1% | 0.44% | +525.4% |
| Q3 2022 | $4,074,000 | +325.7% | 3,452,874 | +560.6% | 0.07% | +69.0% |
| Q2 2020 | $957,000 | – | 522,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |